Forty Seven Prices Initial Public Offering

MENLO PARK, Calif., June 27, 2018 (GLOBE NEWSWIRE) — Forty Seven, Inc. (Nasdaq:FTSV), a clinical stage immuno-oncology company, announced today the pricing of its initial public offering of 7,035,000 shares of common stock at a price to the public of $16.00 per...